1209. Adulteration and misbranding of Estrovin In Oil and sodium morrhuate.
IT. S. v. The Adson-Intrasol Laboratories, Inc. Plea of guilty. Fine,
$500 and 3 years' probation. (F. D. C. No. 7721. Sample Nos. 7697-E,
7698-E, 95341-E.) 
On August 4, 1943, the United States attorney for the Southern District of
New York filed an information against the Adson-Intrasol Laboratories, Inc.,
New York, N. Y., alleging that on or about January 28 and March 11, 1942, the
defendant introduced and caused to be introduced into interstate commerce at
New York, N. Y., for delivery to Los Angeles and San Francisco, Calif., quan-
tities of Estrovin in Oil and sodium morrhuate.
The Estrovin in Oil was alleged to be adulterated in that it purported and was
represented to possess, in each cubic centimeter, a biological activity equivalent
to the activity of 5,000 International Units of estrogenic ovarian follicular hor-
mones, whereas it possessed a biological activity of not more than 1,100 Inter-
national Units of estrogenic ovarian follicular hormones in each cubic centimeter.
It was alleged to be misbranded in that the statements in its labeling, "Estrovin
In Oil * * * 1 c. c. contains therapeutic activity of 5,000 i. u. of estrogenic
ovarian follicular hormones," and "Estrovin In Oil 1 c. c. 5,000 I. U.," were
false and misleading.
The sodium morrhuate was alleged to be adulterated in that it purported and
was represented to contain 5 percent of sodium morrhuate, whereas it contained
not more than 1.1 percent of sodium morrhuate. It was alleged to be misbranded
in that the statements appearing in its labeling, "Sodium Morrhuate * * *
5?," and "Sodium Morrhuate 'Intrasol' is a sterile colloidal solution containing
Sodium Morrhuate    *    *    *    5?," were false and misleading.
On August 23^ 1943, the defendant entered a plea of guilty, and on August 30,
1943, the court imposed a fine of $250 to cover counts 1 and 2, and $250 to cover
counts 3 and 4, a total fine of $500, and placed the defendant on probation for
3 years.